Download Biosketch

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Idiopathic intracranial hypertension wikipedia , lookup

Visual impairment due to intracranial pressure wikipedia , lookup

Blast-related ocular trauma wikipedia , lookup

Glaucoma wikipedia , lookup

Transcript
BIOGRAPHICAL SKETCH
Provide the following information for the Senior/key personnel and other significant contributors in the order listed on Form Page 2.
Follow this format for each person. DO NOT EXCEED FOUR PAGES.
NAME
POSITION TITLE
Carol Toris, Ph.D.
eRA COMMONS USER NAME (credential, e.g., agency login)
ctoris
Professor,
Department of Ophthalmology and Visual Sciences
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and
residency training if applicable.)
INSTITUTION AND LOCATION
Rockford College, Rockford, IL
University of Minnesota, St. Paul, MN
University of Minnesota, St. Paul, MN
DEGREE
(if applicable)
MM/YY
BA
MS
Ph.D.
08/69-05/73
09/77-08/79
09/84-01/90
FIELD OF STUDY
Biology
Animal Physiology
Physiology
A. Personal statement.
I have been studying aqueous humor dynamics since I was a graduate student in the 1980s. My expertise is in
the area of IOP and ocular fluid dynamics. I became Director of Glaucoma Research at the University of
Nebraska Medical Center in 1990. I have published numerous papers on aqueous humor dynamics in rabbits,
cats, dogs, monkeys, and mice. Additionally I have conducted clinical studies of healthy people, patients with
ocular hypertension and various ocular syndromes and patients taking intraocular pressure lowering drugs at
different times of the day and night. My team is comprised of research technicians, animal handlers, and a
glaucoma specialist. Both clinical and animal studies make our work truly translational. We are well skilled and
equipped to undertake the experiments proposed in mice.
B. Positions and Honors
Positions and employment
10/90-06/01
03/93-Present
03/93-06/01
07/01-06/07
07/07-Present
Assistant Professor, Department of Ophthalmology, University of Nebraska Medical Center,
Omaha, NE
Member, Graduate Faculty, University of Nebraska Medical Center, Omaha, NE
Assistant Professor, Courtesy Appointment, Department of Physiology, University of
Nebraska Medical Center, Omaha, NE
Director of Glaucoma Research and Tenured Associate Professor, Department of
Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE
Associate Professor, Courtesy Appointment, Department of Physiology, University of
Nebraska Medical Center, Omaha, NE
Director of Glaucoma Research and Tenured Professor, Department of Ophthalmology and
Visual Sciences, University of Nebraska Medical Center, Omaha, NE
Professor, Courtesy Appointment, Department of Physiology, University of Nebraska
Medical Center, Omaha, NE
Other Experience and Professional Memberships
2004-Present
American Physiological Society
2003-Present
American Glaucoma Society
1984-Present
Association for Research in Vision and Ophthalmology (ARVO), Trustee
1996-Present
International Society for Ocular Fluorometry
1986-Present
International Society for Eye Research (ISER)
1995-Present
Association for Ocular Pharmacology and Therapeutics (AOPT), Trustee
Honors
1969-1973
Jane Addams Scholarship, Rockford College
1989
1993
2006
2009
2010
IJ Fox Memorial Award for graduate research in physiology, University of Minnesota
Ruth Salta Junior Investigator Achievement Award, American Health Assistance
Foundation
Dr. Stan Truhlsen Research Award, Prevent Blindness Nebraska
ARVO FARVO, Gold award
Silver U Award, UNMC
C. Selected peer-reviewed publications most relevant to current application
1. Borghi V, Bastia E, Guzzetta M, Chiroli V, Toris CB, Batugo MR, Carreiro ST, Chong WKM, Gale DC,
Kucera DJ, Liu J, Prasanna G, Kallberg ME, Ongini E, Krauss AHP and Impagnatiello F. A novel nitric
oxide releasing prostaglandin derivative, NCX 125, reduces intraocular pressure in rabbit, dog and
primate models of glaucoma. Journal of Ocular Pharmacology and Therapeutics 2010 26(2): 125-132.
PMID: 20415621
2. Zhao M, Hejkal JJ, Camras CB, Toris CB. Aqueous Humor Dynamics during the Day and Night In
Juvenile and Adult Rabbits. Invest Ophthalmol Vis Sci. 2010 51(6): 3145-51.
3. Camras LJ, Sufficool KE, Camras CB, Fan S, Liu H, Toris CB. Duration of anesthesia affects
intraocular pressure, but not outflow facility in mice. Curr Eye Res. 2010 Sep;35(9):819-27. PMID:
20795864
4. Toris CB, Risma JM, Gonzales-Martinez J, McLaughlin MA, Dawson WW. Aqueous humor dynamics in
inbred rhesus monkeys with naturally occurring ocular hypertension. Exp Eye Res. 2010;91:860-865.
PMID: 20868683
5. Krauss A, Impagnatiello F, Toris CB, Gale D, Prasanna G, Borghi V, Chiroli V, Chong WK, Carreiro S,
Ongini E. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin-F2alpha
agonist, in preclinical models. Exp Eye Res. 2011 Sep;93 (3):250-5. PMID: 21396362
6. Prasanna G, Carreiro S, Anderson S, Gukasyan H, Sartnurak S, Younis H, Gale D, Xiang C, Wells P,
Dinh D, Almaden C, Fortner J, Toris CB, Niesman MR, LaFontaine J, Krauss AH Effect of PF04217329 a Pro-Drug of a Selective Prostaglandin EP2 Agonist on Intraocular Pressure in Preclinical
Models of Glaucoma, Exp Eye Res. 2011 Sep;93 (3):256-64 PMID: 21376717
Additional recent publications of importance to the field (in chronological order)
1. Johnson TV, Fan S, Zhan GL, Camras CB, Toris CB. Efficacy and mechanisms of intraocular pressure
reduction with latanoprost and timolol in subjects with ocular hypertension: a comparison of one and six
weeks of treatment. J Glaucoma. 2010 Aug;19(6):356-64. PMID: 20179619
2. Toris CB, Haecker N, Teasley L, Zhan G, Gulati V, Camras CB. Aqueous humor dynamics in pigment
dispersion syndrome. Arch Ophthalmol. 2010;128(9):1115-1118 PMID: 20837793
3. Lane JT, Larson L, Fan S, Stoner JS, Margalit E, Toris CB. Intraocular Pressure, Blood Pressure,
Ocular Blood Flow, Outflow Facility and Aqueous Humor Flow During a Euglycemic-Hyperinsulinemic
Clamp in Patients With Type 1 Diabetes With Microalbuminuria and Retinopathy. BMC Ophthalmol.
2010 Jun 23;10:19. PMID: 20573241
4. Gulati V, Ghate DA, Camras CB, Toris CB. Correlations between Central Corneal Thickness and
Aqueous Humor Dynamics. Invest Ophthalmol Vis Sci. 2011 Feb 16;52(2):920-6. PMID: 20881287
5. Liu H, Fan S, Gulati V, Camras LJ, Zhan G, Ghate D, Camras CB, Toris CB. Aqueous humor dynamics
during the day and night in healthy mature volunteers. Arch Ophthalmol. 2011 Mar;129(3):269-75.
PMID: 21402980
6. Ahmad I, Balasubramanian S, Del Debbio C, Parameswaran S, Katz AR, Toris C, Fariss RN.
Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular
degeneration. IOVS, 2011 May 2;52(6):2868-78. PMID: 21228388
7. Fan S, Hejkal JJ, Gulati V, Galata SL, Camras CB, Toris CB. Aqueous humor dynamics during the day
and night in volunteers with ocular hypertension. Arch Ophthalmol. 2011 Sep;129(9):1162-6. PMID:
21911663
8. Gulati V, Fan S, Maslonka M, Gangahar C, Toris CB, Diurnal and Nocturnal Variations in Aqueous
Humor Dynamics of Patients with Ocular Hypertension on Medical Therapy. Arch Ophthalmol. 2012
Jun;130 (6):677-84. PMID: 22332206
9. Camras LJ, Yuan F, Fan S, Samuelson TW, Ahmed IK, Schieber AT, Toris CB. A Novel Schlemm’s
Canal Scaffold Increases Outflow Facility in a Human Anterior Segment Perfusion Model. Invest
Ophthalmol Vis Sci 2012 Sep 12;53(10):6115-21. PMID: 22893672
10. Harms NV, Toris CB.Current status of unoprostone for the management of glaucoma and the future of
its use in the treatment of retinal disease. Expert Opin Pharmacother. 2013 Jan;14(1):105-13. PMID:
23199345
11. Gulati V, Fan S, Hays CL, Samuelson TW, Ahmed I, Toris CB. A Novel 8-mm Schlemm’s Canal
Scaffold Reduces Outflow Resistance in a Human Anterior Segment Perfusion Model. Invest
Ophthalmol Vis Sci. 2013;54:000–000. PMID: 23372057
12. Gulati V, Pahuja P, Fan S, Toris CB. An Experimental Steroid Responsive Model of Ocular
Inflammation in Rabbits using an SLT Frequency Doubled Q Switched Nd: YAG Laser. J. Ocular Pharm
Therap, 2013 Sep;29(7):663-9. PMID: 23600959
13. Grierson I, Saheb H, Kahook MY, Johnstone MA, Ahmed IK, Schieber AT, Toris CB. Novel Schlemm’s
Canal Scaffold: Histological Observations, J of G, accepted.
14. Fan S, Gulati V, Neely DG, Agrawal A, Toris CB. Day and nighttime effects of brimonidine on IOP and
aqueous humor dynamics in participants with ocular hypertension, J of Glaucoma, accepted.
D. Ongoing Research Support Toris
ACTIVE
No number
01/01/14-04/30/14
0.60 calendar months
Bascom Palmer seed grant $21,000
New endogenous lipid entities to fulfill unmet needs for glaucoma treatment
The goals of this project are to determine the mechanism whereby endogenous lipids can lower intraocular
pressure.
No number
11/26/13-03/31/2014
0.60 calendar months
Nicox
$11,220
Nitric oxide donating compounds for the treatment of glaucoma
The goals of this project are screen and select new nitric oxide donating compounds for use in glaucoma
therapy.
No number
01/01/2011-03/31/2014 3.12 calendar months
Alcon Research, Ltd.
$215,017
Glaucoma Monkey Model
This study uses monkeys with laser induced glaucoma to study efficacy and mechanism of action of
glaucoma drugs.
No number
07/01/2012-06/30/2014 0.36 calendar months
Ivantis, Inc.
$30,843
Evaluation of Outflow Facility in Human Donor Eyes Implanted with a New Glaucoma Drainage Device
The major goals of this project are to determine whether a new glaucoma drainage device increased
outflow facility in donated human eyes.
No number
01/01/2011-12/31/2014 0.24 calendar months
Allergan, Inc.
$1,261,754
Effects of Ocular Hypotensive Agents on Aqueous Humor Dynamics in Glaucoma Monkeys
This study uses monkeys with laser induced glaucoma to study efficacy and mechanism of action of
glaucoma drugs.
1-R01-EY022124-01
05/14/2012-02/28/2014 1.20 calendar months
University of Michigan
$76,973
Aqueous Humor Dynamics Components that Determine Intraocular Pressure Variance
The major goals of this project are to determine if components of aqueous humor dynamics can predict
whether a person is a responder or non-responder when dosed with a glaucoma drug.
1K23EY023266-01 (Gulati) 04/01/2013-03/31/2018 0.12 calendar months
DHHS/NIH/NEI
$221,790
Study of Aqueous Humor Dynamics in a Pediatric Population
The major goals of this project are to determine whether aqueous humor dynamics in children is different
from adults.